DekaBank Deutsche Girozentrale’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,503
Closed -$2.63M 1248
2025
Q4
$2.63M Hold
15,503
﹤0.01% 709
2025
Q3
$2.72M Hold
15,503
﹤0.01% 692
2025
Q2
$2.15M Hold
15,503
﹤0.01% 729
2025
Q1
$2.82M Hold
15,503
0.01% 669
2024
Q4
$2.44M Hold
15,503
﹤0.01% 708
2024
Q3
$2.72M Hold
15,503
0.01% 699
2024
Q2
$2.83M Hold
15,503
0.01% 686
2024
Q1
$2.71M Hold
15,503
0.01% 696
2023
Q4
$1.97M Hold
15,503
﹤0.01% 776
2023
Q3
$1.81M Sell
15,503
-14,797
-49% -$1.81M ﹤0.01% 766
2023
Q2
$3.47M Hold
30,300
0.01% 633
2023
Q1
$2.35M Hold
30,300
0.01% 696
2022
Q4
$2.38M Hold
30,300
0.01% 684
2022
Q3
$2.11M Hold
30,300
0.01% 698
2022
Q2
$1.92M Buy
30,300
+5,000
+20% +$311K 0.01% 738
2022
Q1
$1.69M Buy
25,300
+16,500
+188% +$1.03M ﹤0.01% 792
2021
Q4
$619K Buy
8,800
+200
+2% +$11.6K ﹤0.01% 1049
2021
Q3
$453K Hold
8,600
﹤0.01% 1073
2021
Q2
$586K Hold
8,600
﹤0.01% 1039
2021
Q1
$622K Buy
8,600
+2,200
+34% +$160K ﹤0.01% 990
2020
Q4
$361K Buy
+6,400
New +$320K ﹤0.01% 1089

Other funds holding KRYS